Revvity Cash on Hand 2010-2025 | RVTY
- Revvity cash on hand for the quarter ending March 31, 2025 was $1.138B, a 32.9% decline year-over-year.
- Revvity cash on hand for 2024 was $1.163B, a 27.43% decline from 2023.
- Revvity cash on hand for 2023 was $1.603B, a 252.82% increase from 2022.
- Revvity cash on hand for 2022 was $0.454B, a 24.69% decline from 2021.
Revvity Annual Cash on Hand (Millions of US $) |
|
---|---|
2024 | $1,163 |
2023 | $1,603 |
2022 | $454 |
2021 | $603 |
2020 | $402 |
2019 | $192 |
2018 | $163 |
2017 | $202 |
2016 | $359 |
2015 | $238 |
2014 | $175 |
2013 | $173 |
2012 | $171 |
2011 | $142 |
2010 | $420 |
2009 | $180 |
Revvity Quarterly Cash on Hand (Millions of US $) |
|
---|---|
2025-03-31 | $1,138 |
2024-12-31 | $1,163 |
2024-09-30 | $1,230 |
2024-06-30 | $1,954 |
2024-03-31 | $1,695 |
2023-12-31 | $1,603 |
2023-09-30 | $1,430 |
2023-06-30 | $2,071 |
2023-03-31 | $2,461 |
2022-12-31 | $454 |
2022-09-30 | $401 |
2022-06-30 | $361 |
2022-03-31 | $670 |
2021-12-31 | $603 |
2021-09-30 | $487 |
2021-06-30 | $573 |
2021-03-31 | $988 |
2020-12-31 | $402 |
2020-09-30 | $258 |
2020-06-30 | $219 |
2020-03-31 | $195 |
2019-12-31 | $192 |
2019-09-30 | $393 |
2019-06-30 | $150 |
2019-03-31 | $134 |
2018-12-31 | $163 |
2018-09-30 | $150 |
2018-06-30 | $163 |
2018-03-31 | $181 |
2017-12-31 | $202 |
2017-09-30 | $709 |
2017-06-30 | $616 |
2017-03-31 | $288 |
2016-12-31 | $359 |
2016-09-30 | $312 |
2016-06-30 | $248 |
2016-03-31 | $211 |
2015-12-31 | $238 |
2015-09-30 | $195 |
2015-06-30 | $192 |
2015-03-31 | $169 |
2014-12-31 | $175 |
2014-09-30 | $204 |
2014-06-30 | $205 |
2014-03-31 | $224 |
2013-12-31 | $173 |
2013-09-30 | $132 |
2013-06-30 | $112 |
2013-03-31 | $126 |
2012-12-31 | $171 |
2012-09-30 | $171 |
2012-06-30 | $171 |
2012-03-31 | $145 |
2011-12-31 | $142 |
2011-09-30 | $248 |
2011-06-30 | $395 |
2011-03-31 | $416 |
2010-12-31 | $420 |
2010-09-30 | $251 |
2010-06-30 | $216 |
2010-03-31 | $182 |
2009-12-31 | $180 |
2009-09-30 | $151 |
2009-06-30 | $151 |
2009-03-31 | $162 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $10.948B | $2.755B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $142.561B | 26.74 |
Elevance Health (ELV) | United States | $88.026B | 11.36 |
CVS Health (CVS) | United States | $80.784B | 10.04 |
Cencora (COR) | United States | $55.036B | 19.15 |
DiDi Global (DIDIY) | China | $23.580B | 35.79 |
Natera (NTRA) | United States | $22.420B | 0.00 |
BioMerieux (BMXMF) | France | $16.097B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.007B | 0.00 |
Solventum (SOLV) | United States | $12.962B | 13.72 |
CochLear (CHEOY) | Australia | $11.342B | 0.00 |
ICON (ICLR) | Ireland | $11.283B | 10.49 |
Doximity (DOCS) | United States | $10.905B | 50.49 |
Viatris (VTRS) | United States | $10.340B | 3.55 |
HealthEquity (HQY) | United States | $9.613B | 42.11 |
Avantor (AVTR) | United States | $9.165B | 13.32 |
Medpace Holdings (MEDP) | United States | $8.574B | 22.77 |
Sonic Healthcare (SKHHY) | Australia | $8.388B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.243B | 14.19 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.238B | 24.96 |
BrightSpring Health Services (BTSG) | United States | $4.157B | 38.48 |
Sotera Health (SHC) | United States | $3.508B | 19.93 |
Surgery Partners (SGRY) | United States | $2.994B | 38.93 |
Alignment Healthcare (ALHC) | United States | $2.924B | 0.00 |
Concentras Parent (CON) | United States | $2.830B | 16.36 |
Organon (OGN) | United States | $2.537B | 2.70 |
GeneDx Holdings (WGS) | United States | $2.066B | 79.58 |
Ardent Health Partners (ARDT) | United States | $1.957B | 8.34 |
Premier (PINC) | United States | $1.900B | 14.43 |
Progyny (PGNY) | United States | $1.883B | 41.45 |
PACS (PACS) | United States | $1.586B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.468B | 29.36 |
Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
Pediatrix Medical (MD) | United States | $1.214B | 9.24 |
Establishment Labs Holdings (ESTA) | $1.113B | 0.00 | |
CareDx (CDNA) | United States | $1.098B | 17.15 |
Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
Agilon Health (AGL) | United States | $0.944B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.818B | 7.66 |
QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
Nutex Health (NUTX) | United States | $0.654B | 9.90 |
Embecta (EMBC) | United States | $0.579B | 3.90 |
LifeMD (LFMD) | United States | $0.566B | 0.00 |
Enhabit (EHAB) | United States | $0.546B | 44.92 |
InnovAge Holding (INNV) | United States | $0.520B | 0.00 |
SBC Medicals (SBC) | United States | $0.507B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
COMPASS Pathways (CMPS) | United Kingdom | $0.437B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.244B | 0.00 |
Oncology Institute (TOI) | United States | $0.232B | 0.00 |
Beauty Health (SKIN) | United States | $0.202B | 0.00 |
DocGo (DCGO) | United States | $0.163B | 26.67 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
Pheton Holdings (PTHL) | China | $0.099B | 0.00 |
So-Young (SY) | China | $0.091B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.081B | 0.00 |
KindlyMD (NAKA) | United States | $0.081B | 0.00 |
OncoCyte (OCX) | United States | $0.080B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
ModivCare (MODV) | United States | $0.050B | 0.00 |
Biodesix (BDSX) | United States | $0.042B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |